Sientra says to resume selling its breast implant devices in U.S.

(Reuters) - Breast implant maker Sientra Inc said it will resume selling all of its medical devices in the U.S. market from March 1, four months after it suspended sales of its breast implant devices to ensure technical compliance.

http://ift.tt/1Lb79mv

from Reuters: Health News
via animenewspro